<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">7601655</journal-id>
<journal-id journal-id-type="pubmed-jr-id">3889</journal-id>
<journal-id journal-id-type="nlm-ta">Gerontology</journal-id>
<journal-id journal-id-type="iso-abbrev">Gerontology</journal-id>
<journal-title-group>
<journal-title>Gerontology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0304-324X</issn>
<issn pub-type="epub">1423-0003</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27974723</article-id>
<article-id pub-id-type="pmc">5310972</article-id>
<article-id pub-id-type="doi">10.1159/000452972</article-id>
<article-id pub-id-type="manuscript">NIHMS828412</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Genome and Epigenome Editing in Mechanistic Studies of Human Aging and Aging-Related Disease</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Lau</surname>
<given-names>Cia-Hin</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Suh</surname>
<given-names>Yousin</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="aff" rid="A5">5</xref>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Genetics, Albert Einstein College of Medicine, Bronx, NY 10461, USA.</aff>
<aff id="A2"><label>2</label>Department of Mechanical and Biomedical Engineering, City University of Hong Kong, Kowloon Tong, HK.</aff>
<aff id="A3"><label>3</label>Department of Biology and Chemistry, City University of Hong Kong, Kowloon Tong, HK.</aff>
<aff id="A4"><label>4</label>Department of Medicine, Albert Einstein College of Medicine, Bronx, NY 10461, USA.</aff>
<aff id="A5"><label>5</label>Department of Ophthalmology and Visual Sciences, Albert Einstein College of Medicine, Bronx, NY 10461, USA.</aff>
<aff id="A6"><label>6</label>Institute for Aging Research, Albert Einstein College of Medicine, Bronx, NY 10461, USA.</aff>
<author-notes>
<corresp id="CR1">Corresponding Authors: Cia-Hin Lau, MS, Department of Mechanical and Biomedical Engineering, Room Y1618, Academic 1, 83 Tat Chee Avenue, City University of Hong Kong, Kowloon Tong, Hong Kong. Phone: 852-3442 2016, <email>lauciahin_4275@yahoo.com</email>, Yousin Suh, PhD, Department of Genetics, Albert Einstein College of Medicine, Michael F. Price Center, 1301 Morris Park Avenue, Room 475, Bronx, NY 10461, USA. Phone: 718-678 1111, <email>yousin.suh@einstein.yu.edu</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>20</day>
<month>12</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>15</day>
<month>12</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>1</month>
<year>2018</year>
</pub-date>
<volume>63</volume>
<issue>2</issue>
<fpage>103</fpage>
<lpage>117</lpage>
<!--elocation-id from pubmed: 10.1159/000452972-->
<abstract>
<p id="P1">The recent advent of genome and epigenome editing technologies has provided a new paradigm in which the landscape of the human genome and epigenome can be precisely manipulated in their native context. Genome and epigenome editing technologies can be applied to many aspects of aging research and offer the potential to development novel therapeutics against age-related diseases. Here, we discuss the latest technological advances in the CRISPR-based genome and epigenome editing toolbox, and provide an insight into how these synthetic biology tools could facilitate aging research by establishing <italic>in vitro</italic> cell- and <italic>in vivo</italic> animal-models to dissect genetic and epigenetic mechanisms underlying aging and age-related diseases. We discuss recent developments in the field with the aims to precisely modulate gene expression and dynamic epigenetic landscapes in a spatial- and temporal- manner in cellular and animal models, by complementing the CRISPR-based editing capability with conditional genetic manipulation tools, including chemically inducible expression system, optogenetics, logic gate genetic circuits, tissue-specific promoters, and serotype-specific adeno-associated virus. We also discuss how the combined use of genome and epigenome editing tools permits investigators to uncover novel molecular pathways involved in pathophysiology and etiology conferred by risk variants associated with aging and aging-related disease. A better understanding of the genetic and epigenetic regulatory mechanisms underlying human aging and age-related disease will significantly contribute to the developments of new therapeutic interventions for extending healthspan and lifespan, ultimately improving the quality of life in the elderly populations.</p>
</abstract>
<kwd-group>
<kwd>Aging</kwd>
<kwd>aging-related disease</kwd>
<kwd>CRISPR</kwd>
<kwd>epigenetics</kwd>
<kwd>genetics</kwd>
<kwd>genome editing</kwd>
<kwd>epigenome editing</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>